David Byram
General Counsel presso BRAEBURN INC.
Profilo
David Byram is currently working as the VP-Market Access & State Government Affairs at Braeburn Pharmaceuticals SPRL and Braeburn, Inc. He has previously worked as the Senior Vice President-Commercial Affairs at Orexo AB and as the Chief Commercial Officer at StageZero Life Sciences Ltd.
Mr. Byram completed his undergraduate degree from Indiana University.
Posizioni attive di David Byram
| Società | Posizione | Inizio |
|---|---|---|
| BRAEBURN INC. | General Counsel | - |
Braeburn Pharmaceuticals SPRL
 Braeburn Pharmaceuticals SPRL Medical SpecialtiesHealth Technology Braeburn Pharmaceuticals SPRL develops and commercializes medical products. It’s a pharmaceutical company focused on novel, long-acting implantable and injectable therapies for serious neurological and psychiatric disorders, including addiction, pain, and schizophrenia. The firm offers Probuohine, CAM2038q1w, CAM2038q4w and Risperdone implant. The company was founded in 2012 and is headquartered in Road Town, British Virgin Islands. | General Counsel | - |
Precedenti posizioni note di David Byram
| Società | Posizione | Fine |
|---|---|---|
| OREXO AB | Corporate Officer/Principal | - |
| STAGEZERO LIFE SCIENCES LTD. | Corporate Officer/Principal | - |
Formazione di David Byram
| Indiana University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| OREXO AB | Health Technology |
| STAGEZERO LIFE SCIENCES LTD. | Health Technology |
| Aziende private | 2 |
|---|---|
Braeburn Pharmaceuticals SPRL
Braeburn Pharmaceuticals SPRL Medical SpecialtiesHealth Technology Braeburn Pharmaceuticals SPRL develops and commercializes medical products. It’s a pharmaceutical company focused on novel, long-acting implantable and injectable therapies for serious neurological and psychiatric disorders, including addiction, pain, and schizophrenia. The firm offers Probuohine, CAM2038q1w, CAM2038q4w and Risperdone implant. The company was founded in 2012 and is headquartered in Road Town, British Virgin Islands. | Health Technology |
Braeburn, Inc.
 Braeburn, Inc. Miscellaneous Commercial ServicesCommercial Services Braeburn, Inc. manufactures pharmaceutical products. It focuses on novel, long-acting implantable and injectable therapies for serious neurological and psychiatric disorders, including addiction, pain and schizophrenia. The firm develops Probuphine for the treatment of adult patients with opioid dependence. The company was founded in 2012 and is headquartered in Princeton, NJ. | Commercial Services |
- Borsa valori
- Insiders
- David Byram
